NOMOX

ESMA_QA_1561

ESMA_QA_1561

Status: ✅ Answer Published

Link to ESMA Q&A tool: https://www.esma.europa.eu/publications-data/questions-answers/1561

Regulatory Context

Regulation : MIFIR

Level 1 Regulation: Markets in Financial Instruments Regulation (MiFIR) Regulation (EU) No 600/2014- Secondary Markets

Level 2 Regulation: No information available

Level 3 Regulation: No information available

Topic: Non-equity transparency

Subject Matter: Scope of Article 9(1)(c) of MiFIR

Question

Submission Date: 04 October 2018

What types of derivatives can benefit from the pre-trade transparency waiver provided under Article 9(1)(c) of MiFIR?

ESMA Answer

Answer Date: 16-10-2024

OTC derivatives specified in Article 8a(2) of MiFIR that are both (i) not subject to the trading obligation as referred to in Article 28 of MiFIR and (ii) for which there is not a liquid market and other derivatives for which there is not a liquid market can benefit from the pre-trade transparency waiver set out under Article 9(1)(c) of MiFIR. 

, 							
		
								

        04-10-2018
  




Original language

        [ESMA 70-872942901-35 MiFIR transparency Q&A, Q&A 4.14]

Only OTC derivatives specified in Article 8a(2) of MiFIR that are both (i) not subject to the trading obligation as referred to specified in Article 28 of MiFIR and (ii) for which there is not a liquid market and other derivatives for which there is not a liquid market can benefit from the pre-trade transparency waiver set out under Article 9(1)(c) of MiFIR.

This document was automatically extracted from the ESMA EMIR Q&A database.

Backlinks